PRACTICAL ONCOLOGY JOURNAL ›› 2018, Vol. 32 ›› Issue (4): 357-361.doi: 10.11904/j.issn.1002-3070.2018.04.015

• Review • Previous Articles     Next Articles

Progress in common chronic inflammatory factors inducing bladder cancer and its immunotherapy

SUN Zugang1,WANG Zhe2,CHEN Huaian2,LIU Shuo2,MIAO Wenlong2   

  1. 1.Graduate Faculty,Hebei North University,Zhangjiakou 075000,China;
    2.Department of Urology,The First Affiliated Hospital of Hebei North University
  • Received:2018-03-20 Online:2018-08-20 Published:2018-09-06

Abstract: More and more evidence shows that uncontrollable inflammation has closely associated with tumorigenesis and development.Chronic inflammation may play a key role in various malignant tumors including bladder cancer.Bladder cancer is the most common malignant tumor of the urinary system.For non-muscle-invasive bladder cancer,the main method is still transurethral resection of bladder tumors,but its recurrence after surgery,the degree of malignancy after recurrence is gradually increased,so the need for postoperative adjuvant drug treatment reduces its recurrence and progression.Nowdays,immunotherapy has become a research hotspot and has achieved good effects.This article briefly describes the common chronic inflammation factors that induce bladder cancer and the related progression on immunotherapy.

Key words: Bladder cancer, Chronic inflammation, Inducing factors, Immunotherapy

CLC Number: